Stryker Corp
NYSE:SYK

Watchlist Manager
Stryker Corp Logo
Stryker Corp
NYSE:SYK
Watchlist
Price: 364.02 USD -0.09% Market Closed
Market Cap: 139.2B USD

Stryker Corp
Income from Continuing Operations

Last Value
3 Years 3Y CAGR
5 Years 5Y CAGR
10 Years 10Y CAGR
Last Value
3 Years 3Y CAGR
5 Years 5Y CAGR
10 Years 10Y CAGR
Quarterly
Annual
TTM
|
See Also

Stryker Corp
Income from Continuing Operations Peer Comparison

Competitors Analysis
Latest Figures & CAGR of Competitors

Company Income from Continuing Operations CAGR 3Y CAGR 5Y CAGR 10Y
Stryker Corp
NYSE:SYK
Income from Continuing Operations
$2.9B
CAGR 3-Years
6%
CAGR 5-Years
11%
CAGR 10-Years
10%
Becton Dickinson and Co
NYSE:BDX
Income from Continuing Operations
$1.7B
CAGR 3-Years
1%
CAGR 5-Years
37%
CAGR 10-Years
9%
Boston Scientific Corp
NYSE:BSX
Income from Continuing Operations
$2.8B
CAGR 3-Years
62%
CAGR 5-Years
N/A
CAGR 10-Years
N/A
Abbott Laboratories
NYSE:ABT
Income from Continuing Operations
$14B
CAGR 3-Years
21%
CAGR 5-Years
33%
CAGR 10-Years
19%
IDEXX Laboratories Inc
NASDAQ:IDXX
Income from Continuing Operations
$1B
CAGR 3-Years
15%
CAGR 5-Years
16%
CAGR 10-Years
19%
Intuitive Surgical Inc
NASDAQ:ISRG
Income from Continuing Operations
$2.8B
CAGR 3-Years
26%
CAGR 5-Years
21%
CAGR 10-Years
18%
No Stocks Found

Stryker Corp
Glance View

Stryker Corporation, a pioneering force in the medical technology industry, traces its roots back to the innovative spirit of Dr. Homer Stryker, an orthopedic surgeon whose dissatisfaction with existing medical equipment spurred him to improve them. Founded in 1941, the company initially focused on new medical devices that addressed specific problems faced by healthcare practitioners. Over the decades, Stryker has evolved into a diversified powerhouse with a portfolio that spans a wide range of products, including joint replacements, surgical equipment, neurotechnology, and spine care solutions. This evolution came through strategic acquisitions and relentless innovation, allowing Stryker to meet the ever-increasing demands of a dynamic healthcare landscape. The company's business model thrives at the intersection of technology and healthcare. With their cutting-edge research and development capabilities, Stryker consistently pushes the envelope in creating sophisticated products that enhance patient outcomes. Revenue streams are predominantly generated from the sale of medical and surgical equipment as well as a myriad of implantable surgical devices used in orthopedic procedures. Stryker’s instruments and solutions are staples in hospitals and clinics worldwide, driven by their commitment to quality and efficacy. Additionally, the company's astute investments in advanced robotics and digital health technologies have positioned it well within the burgeoning field of precision medicine, providing lucrative opportunities to deepen its market entrenchment and expand its competitive edge.

SYK Intrinsic Value
HIDDEN
Show

See Also

What is Stryker Corp's Income from Continuing Operations?
Income from Continuing Operations
2.9B USD

Based on the financial report for Sep 30, 2025, Stryker Corp's Income from Continuing Operations amounts to 2.9B USD.

What is Stryker Corp's Income from Continuing Operations growth rate?
Income from Continuing Operations CAGR 10Y
10%

Over the last year, the Income from Continuing Operations growth was -18%. The average annual Income from Continuing Operations growth rates for Stryker Corp have been 6% over the past three years , 11% over the past five years , and 10% over the past ten years .

Back to Top